Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene Blue Staining and Lesion Detection with Different Bowel Cleansers in Colonoscopy
ChiCTR2600128333Phase 4Completed
- Sponsor
- Puren Hospital Affiliated to Wuhan University of Science and Technology
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of methylene blue in colorectal cancer (CRC) (2 arms), sponsored by Puren Hospital Affiliated to Wuhan University of Science and Technology. Primary endpoint: Methylene blue staining score. Started Jul 2026; status: completed.
02
Drugs
methylene blue
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ChiCTR2600128333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600128333.